Skip to main content

Peer Review reports

From: Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study

Original Submission
6 Sep 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Oct 2023 Reviewed Reviewer Report - Eunyoung Lee
1 Dec 2023 Reviewed Reviewer Report
15 Dec 2023 Author responded Author comments - Lixin Xie
Resubmission - Version 3
15 Dec 2023 Submitted Manuscript version 3
15 Dec 2023 Author responded Author comments - Lixin Xie
Resubmission - Version 4
15 Dec 2023 Submitted Manuscript version 4
15 Dec 2023 Author responded Author comments - Lixin Xie
Resubmission - Version 5
15 Dec 2023 Submitted Manuscript version 5
20 Dec 2023 Reviewed Reviewer Report
20 Dec 2023 Reviewed Reviewer Report - Eunyoung Lee
22 Dec 2023 Author responded Author comments - Lixin Xie
Resubmission - Version 6
22 Dec 2023 Submitted Manuscript version 6
Publishing
29 Dec 2023 Editorially accepted
8 Jan 2024 Article published 10.1186/s12879-023-08965-8

You can find further information about peer review here.

Back to article page